These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30909753)

  • 41. Release Mechanism Between Ion Osmotic Pressure and Drug Release in Ionic-Driven Osmotic Pump Tablets (I).
    Cheng L; Gao S; Ouyang D; Wang H; Wang Y; Pan W; Yang X
    AAPS PharmSciTech; 2018 Feb; 19(2):803-811. PubMed ID: 29019066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hot melt granulation: a facile approach for monolithic osmotic release tablets.
    Panda RR; Tiwary AK
    Drug Dev Ind Pharm; 2012 Apr; 38(4):447-61. PubMed ID: 21954892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Studies on preparation and dissolution test in vitro of intragastric floating two-chamber osmotic pump tablets of total alkaloids of Coptis chinensis and Evodia rutaecarpa].
    Fang Y; Shi QW
    Zhong Yao Cai; 2011 May; 34(5):779-82. PubMed ID: 21954566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and in Vitro Evaluation of Osmotic-Pump Lorcaserin-hydrochloride Controlled-Release Tablets.
    Song Q; Jiang C; Wang C; Zhou L; Han Z; Sun N; Huang P; Wang D
    Chem Pharm Bull (Tokyo); 2022; 70(3):202-210. PubMed ID: 35228384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation.
    Gong W; Ma R; Mei D; Jing P; Dong X; Li B; Yang Y; Du L; Mei XG; Hu FQ
    Drug Deliv; 2014 Feb; 21(1):1-7. PubMed ID: 24102136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Preparation and Synchronized Release Behavior on Porosity Osmotic Pump Tablets of Total Glucosides of Paeony].
    Wu XC; Hao HJ; Song XY; Liu YX; Zhang YZ; Zhang HQ
    Zhong Yao Cai; 2016 Feb; 39(2):363-6. PubMed ID: 30080371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monolithic osmotic tablet system for nifedipine delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    J Control Release; 2000 Jul; 67(2-3):309-22. PubMed ID: 10825563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Production and
    Ma C; Huang Z; Zhu Y; Chen X; Singh V; Huang Y; Pan X; Wu C
    Pharmazie; 2017 Sep; 72(9):511-517. PubMed ID: 29441977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network].
    Zhang ZH; Wang Y; Wu WF; Zhao X; Sun XC; Wang HQ
    Yao Xue Xue Bao; 2012 Dec; 47(12):1687-95. PubMed ID: 23460977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delivery of prazosin hydrochloride from osmotic pump system prepared by coating the core tablet with an indentation.
    Liu L; Wang J; Zhu S
    Drug Deliv; 2007 Apr; 14(4):219-24. PubMed ID: 17497354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel controlled porosity osmotic pump system for sodium ferulate.
    He L; Gong T; Zhao D; Zhang ZR; Li L
    Pharmazie; 2006 Dec; 61(12):1022-7. PubMed ID: 17283661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
    Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
    Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets.
    Abd-Elbary A; Tadros MI; Alaa-Eldin AA
    AAPS PharmSciTech; 2011 Jun; 12(2):485-95. PubMed ID: 21479749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sustained release formulation of Ondansetron HCl using osmotic drug delivery approach.
    Gundu R; Pekamwar S; Shelke S; Shep S; Kulkarni D
    Drug Dev Ind Pharm; 2020 Mar; 46(3):343-355. PubMed ID: 31937128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visualized analysis and evaluation of simultaneous controlled release of metformin hydrochloride and gliclazide from sandwiched osmotic pump capsule.
    Gao S; Chen Y; Hu R; Lu W; Yu L; Chen J; Liu S; Guo Y; Shen Q; Wang B; Fang W
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1776-1786. PubMed ID: 32895014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin.
    Chen H; Jiang G; Ding F
    Drug Dev Ind Pharm; 2009 Feb; 35(2):131-7. PubMed ID: 19169941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel bi-layer ascending release osmotic pump tablet: in vitro investigation and in vivo investigation in pharmacokinetic study and IVIVC evaluation.
    Xu H; Li Z; Pan H; Zhang Z; Liu D; Tian B; Ma S; Song S; Pan W
    Int J Pharm; 2013 Dec; 458(1):181-7. PubMed ID: 24095815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osmotic capsules: A universal oral, controlled-release drug delivery dosage form.
    Waterman KC; Goeken GS; Konagurthu S; Likar MD; MacDonald BC; Mahajan N; Swaminathan V
    J Control Release; 2011 Jun; 152(2):264-9. PubMed ID: 21315121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.